However, EGFR over-expression is not always homogenous in tumors, and a certain degree of cell surface HER-2 and TfR over-expression is also found in patients with PDAC [24,61] and HNSCC [27,31,78], as described earlier. Here, TFRC is linked to head and neck squamous cell carcinoma.